Mod­er­na dis­putes NIH claims on Covid-19 vac­cine patents, says it of­fered to make gov­ern­ment co-own­ers

Mod­er­na on Thurs­day af­ter­noon is­sued a quick re­but­tal to re­cent NIH claims on its Covid-19 vac­cine patents, say­ing that the mR­NA se­quence for the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.